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The Nano Spray Dryer B-90 offers a new, simple, and alternative approach for the production of drug nanocrystals.
Among attractive drugs, calpain inhibitor that inhibits programmed cell death ‘apoptosis’ is a candidate for curing
apoptosis-mediated intractable diseases such as Alzheimer’s disease and Parkinson’s disease. In this study, the
preparation of calpain inhibitor nanocrystals using Nano Spray Dryer B-90 was demonstrated. The particle sizes
were controlled by means of selecting mesh aperture sizes. The obtained average particle sizes were in the range
of around 300 nm to submicron meter.
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Using drug nanoparticles for a drug delivery system has
attracted considerable attentions in the field of nanome-
dicine. Especially, nanoparticles with a drug filling rate
of 100% including their amorphous form are called drug
nanocrystals [1]. Since a nanocrystal has large surface
area compared to a microparticle, the drug nanocrystal
has several unique peculiarities such as its increased
dissolution velocity, increased saturation velocity, and
increased adhesiveness to cell membranes [2]. Addition-
ally, drug nanocrystals are able to deliver large amount
of drugs into cells and tissues at a single particle level
because of their densely packed crystal structure [2].
Because of their unique physicochemical properties, re-
cently, drug nanocrystals have been considered as a
novel type of drug formulation for the drug delivery
system [3].
Several approaches for preparing drug nanocrystals are
classified as top-down and bottom-up procedures [4].
For the top-down procedures, techniques of milling,
homogenization, and laser ablation are reported. For the
bottom-up procedures, techniques of precipitation, chem-
ical vapor, emulsion, and spray dryer are representatives.
However, for the top-down procedures, all media milling
processes involve high-energy input and are highly* Correspondence: koichi.baba@ophthal.med.osaka-u.ac.jp
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reproduction in any medium, provided the originefficient, and a considerable amount of heat is generated
in these operations, making processing of thermolabile
materials difficult. The contamination of milling balls that
should be removed from drug dispersions by some efforts
is also a problem, whereas for the bottom-up procedures,
the removal of harsh solvents used for the preparation
processes of drug dispersions is necessary in the precipita-
tion technique [1]. Since the spray dryer technique takes a
facile approach for preparing nanoparticles, which carries
out spraying, evaporating the solvent-dissolved drug, and
collecting drug particles, numerous drugs can be candi-
date for nanoparticle preparation in this technique. How-
ever, it is difficult for conventional spray dryer techniques
to prepare particles with less than 2 μm in size and also
to collect their fine particles [5]. In other words,
submicrometer-sized particles, i.e., nanoparticles, cannot
be obtained using the conventional spray dryer. Recently,
an advanced spray dryer technology, Nano Spray Dryer
B-90, has been developed by BüchiW (Flawil, Switzerland)
[6]. The functions of piezoelectrically driven vibrating
mesh and electrostatic particle collector realize the suc-
cessful preparation and collection of nanoparticles. The
different mesh aperture sizes create different sizes of
nanoparticles. Currently, drug-encapsulated polymeric
nanoparticles [7], protein nanoparticles [8], and lithium
carbonate (Li2CO3) hollow spheres used in lithium batter-
ies [9] have been successfully prepared using Nano Spray
Dryer B-90.is is an Open Access article distributed under the terms of the Creative
mmons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
inal work is properly cited.
a) Calpain inhibitor I 
b) SNJ-1945 
Figure 1 Chemical structures of calpain inhibitor I (a) and
SNJ-1945 (b).
Figure 2 Schematic image of Nano Spray Dryer B-90.
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inhibitor nanocrystals. Calpain inhibitors inhibit the cal-
pain activity, resulting in reducing the calpain-meditated
apoptosis [10]. Several kinds of calpain inhibitors have
been synthesized such as leupeptin which improves
motor neuron survival in rat embryos and calpain in-
hibitor VI (SJA6017) and calpain inhibitor XI [Z-L-Abu-
CONH(CH2)3-morpholine] which are used for protect-
ing both retinal and cortical neurons, respectively,
against ischemia-induced damage [10]. Furthermore, cal-
pain inhibitors are currently one of the most attractive
drugs for curing intractable diseases such as Alzheimer’s
disease and Parkinson’s disease [10]. In this research, we
demonstrated the preparation of calpain inhibitor nano-
crystals in powder conditions using Nano Spray Dryer
B-90. The calpain inhibitor drugs selected were calpain
inhibitor I (Figure 1a) [11] and ((1 S)-1-((((1 S)-1-benzyl-
3-cyclopropylamino-2,3-di-oxopropyl)amino)carbonyl)-
3-methylbutyl)carbamic acid 5-methoxy-3-oxapentyl ester
(SNJ-1945; Figure 1b) [12]. Since it is known that the
mesh aperture size significantly controls the resulting
particle size [13], we investigated the relationship be-
tween mesh aperture size and particle size of drugs.
Additionally, we briefly noted the effects of the con-
centration of dissolved drug solution, inlet temperature,
and gas flow rate on the resulting particle size, especially
targeting SNJ-1945 nanocrystals.
Figure 3 SEM images of calpain inhibitor I nanocrystals. The nanocrystals were prepared using mesh with aperture sizes of 4.0 (a), 5.5 (b),
and 7.0 μm (c).
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Figure 4 SEM images of SNJ-1945 nanocrystals. The nanocrystals were prepared using mesh with aperture sizes of 4.0 (a), 5.5 (b),
and 7.0 μm (c).
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Particle size: 813± 484 nm
n = 337
n = 336
Figure 5 Average sizes with their size distribution of calpain
inhibitor I nanocrystals. The used mesh aperture sizes were 4.0 (a),
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Particle size: 845± 567 nm
n = 331
Figure 6 Average sizes with their size distribution of SNJ-1945
nanocrystals. The used mesh aperture sizes were 4.0 (a), 5.5 (b),
and 7.0 μm (c). ‘n’ represents the number of counted particles.
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Table 1 Particle size and size distribution of SNJ-1945 nanocrystals prepared at different experimental conditions
Experimental conditions Samples
Case I Case II Case III Case IV
Concentration (mg/ml) 5:10 50:10 5:10 5:10
Tin (°C) 50 50 100 50
Flow rate (L/min) 100 100 100 150
Particle size and size distribution (nm) 418 ± 138 994 ± 360 515 ± 197 536 ± 230
The mesh aperture size used was 4.0 μm.
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The calpain inhibitor I and ethanol (99.5% v/v) were pur-
chased from Wako Pure Chemical Industries (Osaka-shi,
Osaka, Japan). The calpain inhibitor SNJ-1945 was kindly
provided by Senju Pharmaceutical Co., Ltd. (Kobe-shi,
Hyogo, Japan). Each drug was dissolved in ethanol (5 mg/
10 ml). Then, each ethanol-dissolved drug solution was
used for preparing each nanocrystal using Nano Spray
Dryer B-90 (BüchiW). A schematic image of Nano Spray
Dryer B-90 is illustrated in Figure 2. Briefly, the drying
gas, which is heated up to the setting inlet temperature,
flows into the drying chamber, and then the gas exits from
the spray dryer passing through the clearing filter at the
bottom. The inlet temperature and outlet temperature are
shown as Tin and Tout, respectively. The operating condi-
tions for the experiments were kept constant at Tin = 50°C,
Tout = 35°C, feed rates of 25 ml/h, and a drying gas flow
rate of 100 L/min. Spray mesh aperture sizes of 4.0, 5.5,
and 7.0 μm were used in this experiment. Finally, the
resulting nanocrystal powders were collected using a rub-
ber spatula. The morphology and size of collected parti-
cles were observed by scanning electron microscopy
(SEM; JEOL-6510LA, Akishima-shi, Tokyo, Japan). The
average size and particle size distribution were calculated
by means of counting more than 300 particles from the
obtained SEM images.
Results and discussion
The ethanol-dissolved drug solution was fed to the
spray head by pumping. The solution was atomized by
piezoelectrically driven mesh vibration in a small spray
cap, and then millions of precisely sized droplets per
second with a narrow distribution were ejected by the
vibrating actuator driven at around 60 kHz. The ex-
tremely fine droplets were dried to become solid parti-
cles while passing through the chamber, and then
these particles, which were electrostatically charged by
dry gases of N2 and CO2, were collected by the elec-
trode. The collected particles using the rubber spatula
were observed by SEM. The morphology of each cal-
pain inhibitor nanocrystal was sphere-like regardless of
mesh aperture sizes of 4.0, 5.5, and 7.0 μm (Figures 3
and 4). On the other hand, their particle sizes were as-
sociated with the mesh aperture sizes. For the calpaininhibitor I nanocrystals, the average particle sizes with
their size distribution were 378 ± 132, 527 ± 284, and
813 ± 484 nm against mesh aperture sizes of 4.0, 5.5,
and 7.0 μm, respectively (Figure 5). For the SNJ-1945
nanocrystals, the average particle sizes with their size
distribution were 418± 138, 605± 369, and 845± 567 nm
against mesh aperture sizes of 4.0, 5.5, and 7.0 μm, re-
spectively (Figure 6). For both cases of calpain inhibitor I
and SNJ-1945 nanocrystals, the average particle size as
well as their size-distribution width relating to particle
polydispersity became small and narrow with decreasing
mesh aperture sizes, respectively. The validity of these
results is supported by previous reports that the different
mesh aperture sizes resulted in making different sizes with
size-distribution widths of particles, e.g., average particle
size and size-distribution width decreased with decreasing
mesh aperture size [13]. This is because the small mesh
aperture size (e.g., 4.0 μm) tends to generate small-sized
droplets of the ethanol-dissolved drug solution, which
results in creating small-sized particles with narrow size-
distribution widths, compared to utilizing the large mesh
aperture size (e.g., 7.0 μm). We revealed that the selection
of mesh aperture sizes controlled the particle sizes of cal-
pain inhibitor I and SNJ-1945 nanocrystals.
We also investigated the effects of the experimental
conditions relating to the concentration of ethanol-
dissolved drug solution, Tin, and gas flow rate on the
resulting particle size, which were compared with
those of the standard sample of SNJ-1945 nanocrys-
tals. The standard sample of SNJ-1945 nanocrystals
(418 ± 138 nm in size) was prepared with the following
experimental conditions: concentration = 5 mg/10 ml,
Tin = 50°C, gas flow rate = 100 L/min, and mesh aper-
ture size = 4.0 μm (see the data of the standard sample
in Figures 4a and 6a, and case I in Table 1). It was re-
vealed that the concentration significantly affected the
particle size, namely when the concentration increased
tenfold (50 mg/10 ml), the particle size increased al-
most twice compared to the effect of utilizing the
concentration (5 mg/10 ml) of the standard sample
(cases I and II in Table 1). The image of the particles
obtained by SEM observation is shown in Figure 7a.
The average particle size and their size distribution
was 994 ± 360 nm (Figure 8a). On the other hand, the
Figure 7 SEM images of SNJ-1945 nanocrystals. The nanocrystals were prepared using mesh with aperture size of 4.0 μm at different
experimental conditions, especially focusing on concentration (a), Tin (b), and gas flow rate (c).




























































































Particle size: 994± 360 nm
 n = 319
n = 314
n = 366
Figure 8 Average sizes with their size distribution of SNJ-1945
nanocrystals. The nanocrystals were prepared using mesh with
aperture size of 4.0 μm at different experimental conditions,
especially focusing on concentration (a), Tin (b), and gas flow rate (c).
‘n’ represents the number of counted particles.
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(150 L/min) did not significantly affect the particle size
compared to the effect of utilizing high concentration
of 50 mg/10 ml (cases I to IV in Table 1). The images
of the particles obtained by SEM observation at the
conditions of Tin = 100°C and gas flow rate = 150 L/min
are shown in Figure 7b,c, respectively. The average par-
ticle size and their size distribution at the conditions of
Tin = 100°C and gas flow rate = 150 L/min were 515 ±
197 and 536 ± 230 nm, respectively (Figure 8b,c). These
obtained results seemed to be reasonable when con-
sidering previous reports [13,14], namely the particle
size was significantly affected by the concentration of
ethanol-dissolved drug solution, but not significantly by
Tin and gas flow rate. More detailed experimental con-
ditions related to the concentration of dissolved drug so-
lution, temperature, and gas flow rate, which will affect
particle formation, will be investigated as future works
including several kinds of calpain inhibitor nanocrystals.
Conclusions
We succeeded in preparing size-controlled calpain in-
hibitor nanocrystals using Nano Spray Dryer B-90. To
the best of our knowledge, this is the first time to pre-
pare calpain inhibitor nanocrystals. The particle sizes
were associated with the mesh aperture sizes, namely
when the mesh aperture sizes decreased, the particle
sizes decreased. The concentration of ethanol-dissolved
drug solution significantly affected the particle size.
Calpain inhibitors will be a promising drug for curing
intractable diseases such as Alzheimer’s disease and
Parkinson’s disease. Therefore, utilizing the calpain-
inhibitor-nanocrystal-based drug delivery system tar-
geting such intractable diseases will be quite attractive
topics in the near future, and thus our fundamental find-
ings of preparing calpain inhibitor nanocrystals in this
research are noteworthy. We are also investigating the
preparation of water dispersion of calpain inhibitor nano-
crystals. This nanocrystal water dispersion will act as
attractive nanocrystal-based eye drops for the treatment
of ophthalmic disorders such as Fuchs’ endothelial
dystrophy of the cornea in the near future.
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